Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peivand Bastani
Cost-Utility Analysis of Adjuvant Therapies for Breast Cancer in Iran
International Journal of Technology Assessment in Health Care
Health Policy
Related publications
Cost-Utility Analysis of Adjuvant Trastuzumab Therapy for HER2-positive Early-Stage Breast Cancer in the Philippines
BMC Health Services Research
Health Policy
Pcn181 - Cost-Utility Analysis of Adjuvant Pertuzumab-Based Regimen in Women With Her2-Positive Breast Cancer in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cyclophosphamide and Tamoxifen as Adjuvant Therapies in the Management of Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Cost Considerations in Determining the Affordability of Adjuvant Trastuzumab in Breast Cancer
South African Medical Journal
Medicine
Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis
Frontiers in Oncology
Cancer Research
Oncology
Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study
PLoS ONE
Multidisciplinary
PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Adjuvant Chemotherapy for Early Breast Cancer.
BMJ